CompuGroup Financial Statements From 2010 to 2025

Stocks . UK . 
Stock . CompuGroup Medical AG
0MSD Stock   16.22  6.04  27.13%   
CompuGroup Medical financial statements provide useful quarterly and yearly information to potential CompuGroup Medical AG investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CompuGroup Medical financial statements helps investors assess CompuGroup Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CompuGroup Medical's valuation are summarized below:
Gross Profit
380.7 M
Profit Margin
0.0212
Market Capitalization
2 B
Revenue
1.2 B
Earnings Share
1.444
There are over seventy-eight available fundamental signals for CompuGroup Medical AG, which can be analyzed over time and compared to other ratios. All traders should validate CompuGroup Medical's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.

CompuGroup Medical Total Revenue

1.43 Billion

Check CompuGroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CompuGroup Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 139.8 M, Interest Expense of 29.4 M or Selling And Marketing Expenses of 10.9 M, as well as many indicators such as . CompuGroup financial statements analysis is a perfect complement when working with CompuGroup Medical Valuation or Volatility modules.
  
This module can also supplement various CompuGroup Medical Technical models . Check out the analysis of CompuGroup Medical Correlation against competitors.

CompuGroup Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.3 B2.2 B1.2 B
Slightly volatile
Total Current Liabilities220.4 M398.9 M226.6 M
Slightly volatile
Total Stockholder Equity806.2 M767.8 M381.7 M
Slightly volatile
Property Plant And Equipment Net200.1 M190.6 M105.4 M
Slightly volatile
Retained Earnings738.1 M702.9 M372.2 M
Slightly volatile
Cash42.4 M74.1 M43.2 M
Slightly volatile
Non Current Assets Total1.8 B1.8 B945.5 M
Slightly volatile
Non Currrent Assets Other53.4 M50.8 M27.2 M
Slightly volatile
Cash And Short Term Investments43.1 M74.2 M43.9 M
Slightly volatile
Common Stock Shares Outstanding55.5 M60.3 M51.3 M
Slightly volatile
Liabilities And Stockholders Equity2.3 B2.2 B1.2 B
Slightly volatile
Inventory11.5 M21.7 M13.2 M
Slightly volatile
Other Current Assets46.9 M86.6 M55.7 M
Slightly volatile
Total Liabilities1.5 B1.4 B802.2 M
Slightly volatile
Total Current Assets446.6 M425.3 M239 M
Slightly volatile
Common Stock58.2 M61.8 M53.7 M
Slightly volatile
Accounts Payable99.3 M94.6 M51.9 M
Slightly volatile
Short Term Debt49.4 M29.7 M41.5 M
Slightly volatile
Short and Long Term Debt Total448.1 M882 M468 M
Slightly volatile
Current Deferred Revenue265.7 M253.1 M116.8 M
Slightly volatile
Short Term Investments70.1 K73.8 K728.5 K
Slightly volatile
Non Current Liabilities Total1.1 B1 B557 M
Slightly volatile
Intangible Assets419.2 M719.6 M408.3 M
Slightly volatile
Good Will414.6 M786.7 M385.2 M
Slightly volatile
Long Term Debt402.9 M540.7 M380.2 M
Slightly volatile
Property Plant Equipment129.9 M185 M109.1 M
Slightly volatile
Other Liabilities134.3 M186.3 M111.2 M
Slightly volatile
Deferred Long Term Liabilities960 K1.1 M1.2 M
Slightly volatile

CompuGroup Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization139.8 M133.2 M68.2 M
Slightly volatile
Interest Expense29.4 M28 M12.7 M
Slightly volatile
Selling And Marketing Expenses10.9 M10.4 M10.3 M
Slightly volatile
Total Revenue1.4 B1.4 B747.3 M
Slightly volatile
Gross Profit1.2 B1.2 B628.8 M
Slightly volatile
Other Operating Expenses1.2 B1.2 B650.6 M
Slightly volatile
Operating Income187.4 M178.4 M98.2 M
Slightly volatile
EBIT77.2 M115 M84.5 M
Slightly volatile
EBITDA135 M248.2 M147.5 M
Slightly volatile
Total Operating Expenses1.2 B1.2 B564.7 M
Slightly volatile
Income Before Tax62.2 M83.6 M70.9 M
Slightly volatile
Net Income41.7 M52.8 M45.2 M
Slightly volatile
Income Tax Expense23.4 M29.7 M25.8 M
Slightly volatile
Selling General Administrative47.5 M25.6 M56.9 M
Slightly volatile
Research Development304.5 M290 M88.3 M
Slightly volatile
Tax Provision39.6 M42.6 M34.5 M
Slightly volatile
Interest Income8.8 M9 M8.6 M
Slightly volatile
Net Income Applicable To Common Shares71.2 M84.4 M59.3 M
Slightly volatile
Minority Interest230.8 K243 K1.2 M
Slightly volatile

CompuGroup Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow61.1 M119.7 M68.9 M
Slightly volatile
Begin Period Cash Flow109.3 M104.1 M50.1 M
Slightly volatile
Depreciation139.8 M133.2 M62 M
Slightly volatile
Total Cash From Operating Activities216.8 M206.5 M109.4 M
Slightly volatile
Net Income41.5 M53.9 M45.2 M
Slightly volatile
End Period Cash Flow45 M74.1 M45.8 M
Slightly volatile

CompuGroup Fundamental Market Drivers

Cash And Short Term Investments64.5 M

About CompuGroup Medical Financial Statements

CompuGroup Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although CompuGroup Medical investors may analyze each financial statement separately, they are all interrelated. The changes in CompuGroup Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on CompuGroup Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue253.1 M265.7 M
Total Revenue1.4 B1.4 B
Cost Of Revenue210 M220.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CSXCSX Corporation
ETONEton Pharmaceuticals
ALLTAllot Communications

Additional Tools for CompuGroup Stock Analysis

When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY